Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting.

Damiana, T S T; Paraïso, P; de Ridder, C; Stuurman, D; Seimbille, Y; Dalm, S U

Damiana, T S T; Paraïso, P; de Ridder, C; Stuurman, D; Seimbille, Y; Dalm, S U.

Afiliação

Damiana TST; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Paraïso P; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
de Ridder C; Department of Experimental Urology, Erasmus Medical Center, Rotterdam, The Netherlands.
Stuurman D; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Seimbille Y; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Dalm SU; Department of Radiology & Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. s.dalm@erasmusmc.nl.

Eur J Nucl Med Mol Imaging ; 50(13): 3851-3861, 2023 11.

Article em En | MEDLINE | ID: mdl-37584725

Assuntos

Neoplasias da Próstata; Receptores da Bombesina; Animais; Humanos; Masculino; Camundongos; Transporte Biológico; Bombesina; Linhagem Celular Tumoral; Neoplasias da Próstata/patologia; Receptores da Bombesina/metabolismo; Distribuição Tecidual

Palavras-chave

GRPR; NeoB; Peptide receptor radionuclide therapy; Prostate cancer; RM2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Receptores da Bombesina Limite: Animals / Humans / Male Idioma: En Revista: Eur J Nucl Med Mol Imaging Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google